google scholar bpc 157 Stable Gastric Pentadecapeptide 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions BPC-157 - Rocky Mountain Peptides

Moreover, additional supportive evidence for BPC 157 (i.e., no toxic effect, limit test negative, lethal dose LD1 not achieved, no side-effects in trials (for review, see [1,3,4,5,6,8,9,32,33,34,35,36])) shows that it inhibits the growth of several tumor cell lines and counteracts the tumor-promoting effect of VEGF [142]

Supplier Verification : Working with established suppliers who provide comprehensive testing documentation and quality assurance

Q: Where should this medicine be stored

Comparison to Psychiatric Medications Reveals Theoretical Advantages but Critical Unknowns BPC-157s preclinical profile suggests potential advantages over conventional psychiatric medications, but the comparison is fundamentally unfair

J Psychopharmacol

If math is not your strength, that is perfectly fine